Sean Brady, PhD, microbiologist and associate professor at The Rockefeller University in New York City, recently conducted a study examining the diversity of life in soil samples, looking for undiscovered treatments.
This led to a discovery of a new molecule, mixed into antibiotics called malacidins, which killed several superbugs in laboratory rats without developing resistance.
“A significant fraction of the drugs we use today in the clinic, especially antibiotics, come from characterizing molecules that are produced by living things, particularly bacteria,” Dr. Brady told Healthline.
More articles on clinical leadership and infection control:
100+ cases of foodborne illness attributed to McDonald’s salad
HHS invests $24M to develop at-home flu tests
Why EDs need language interpreters to prevent patient harm
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.